Clover Health Investments, Corp. (CLOV) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Clover Health Investments, Corp. (CLOV) Earnings Overview
As of July 8, 2026, Clover Health Investments, Corp. (CLOV) reported trailing twelve-month net income of -$57M, reflecting -93.6% year-over-year growth. The company earned $-0.11 per diluted share over the past four quarters, with a net profit margin of -4.4%.
Looking at the long-term picture, CLOV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$43M in fiscal 2024.
Clover Health Investments, Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HUM ($1.13B net income, 0.9% margin), CVS ($2.93B net income, 0.4% margin), ELV ($5.24B net income, 2.8% margin), CLOV has room to improve margins relative to the peer group. Compare CLOV vs HUM →
CLOV Earnings vs Peers
Earnings metrics vs comparable public companies
CLOV Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$86M | -98.9% | -$86M | $-0.17 | -4.4% | -4.4% |
| 2024 | -$43M | +79.8% | -$46M | $-0.09 | -3.1% | -3.3% |
| 2023 | -$213M | +37.2% | -$205M | $-0.45 | -16.9% | -16.3% |
| 2022 | -$340M | +42.2% | -$287M | $-0.71 | -31.0% | -26.1% |
| 2021 | -$588M | -330.9% | -$637M | $-1.25 | -39.9% | -43.3% |
| 2020 | -$136M | +62.5% | -$93M | $-0.23 | -20.3% | -13.8% |
| 2019 | -$364M | -80.1% | -$183M | $-0.90 | -78.7% | -39.6% |
| 2018 | -$202M | - | -$186M | $-4.81 | -71.9% | -66.1% |
Download Data
Export CLOV earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CLOV — Frequently Asked Questions
Quick answers to the most common questions about buying CLOV stock.
What is CLOV earnings per share (EPS)?
CLOV trailing twelve-month (TTM) diluted EPS is $-0.11, reflecting -93.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Clover Health Investments, Corp.'s net income?
Clover Health Investments, Corp. (CLOV) trailing twelve-month net income is $-57M as of 2025. Earnings declined -93.6% year-over-year.
Is CLOV profitable?
CLOV is not currently profitable on a TTM basis, reporting a net loss of $-57M. Net margin is -4.4%. Investors should monitor for a return to profitability.
What is CLOV's earnings growth rate?
CLOV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are CLOV's profit margins?
Clover Health Investments, Corp. net profit margin is -4.4%, operating margin is -4.4%, and gross margin is +18.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -26.3%.
Is CLOV growing earnings?
CLOV earnings are declining — EPS fell -93.6% year-over-year. TTM net income dropped to $-57M. This contrasts with the 5-year CAGR of N/A.
What was CLOV's best earnings year?
Clover Health Investments, Corp.'s highest annual net income on record is $-43M, achieved in fiscal year 2024. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were CLOV's earnings last quarter?
CLOV's most recent reported quarter was Q1 2026. Net income was $27M with diluted EPS of $0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.